Latest Biogen News & Updates
See the latest news and media coverage for Biogen. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company for neurological, immune, and rare diseases
biogen.com- Headquarters
- Cambridge, United States
- Company type
- Public company
- Number of employees
- 7,500–10,000
Latest news about Biogen
Company announcements
-
Biogen doses first patient in Phase 3 SMA study
This milestone advances potential new treatments for SMA patients and families. Ongoing research targets unmet needs.
-
Biogen hosts Q1 2026 financial results webcast
It starts soon at 8AM ET. Interested parties can join live.
-
Biogen reports first quarter 2026 results
The announcement was made on April 29, 2026. A detailed document is available for download.
-
Biogen enters agreement with TJ Biopharma for felzartamab assets
Biogen acquires exclusive rights in Greater China for $100M upfront plus up to $850M milestones and royalties. This consolidates worldwide rights for the CD38 antibody in immune diseases.
Media coverage
-
FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate
The FDA is looking at a slew of label expansions this month, including one that could open up home-based treatments for Alzheimer's disease.
-
Biogen Inc. (BIIB) - Q1 2026 Earnings Beat Drives 6% Single-Day Gain Despite Full-Year Guidance Cut
We combine multiple analytical approaches to ensure our subscribers receive well-rounded perspectives on market opportunities. Biogen Inc. (NASDAQ: BIIB) outperformed broader biotech indices ...
-
Biogen beats profit expectations as demand for newer rare-disease drugs fuel growth
Biogen reports strong first-quarter earnings with rising sales from new Alzheimer's and rare-disease treatments, despite declining demand for older multiple sclerosis drugs. The drugmaker's strategy...
-
Biogen agrees $850m felzartamab rights deal with TJ Biopharma
Biogen has entered into an agreement with TJ Biopharma (TJ Bio) to acquire exclusive rights to felzartamab in the Greater China region, further extending its...
Track Biogen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Biogen competitors & trending companies
Browse news for competitors to Biogen and other trending companies.
UCB
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group